A gene for dominant nonspecific X-linked mental retardation is located in Xq28. 1997

V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
INSERM U129-ICGM, Faculté de Médecine Cochin, Paris, France.

A large family (MRX48) with a nonspecific X-linked mental retardation condition is described. An X-linked semidominant inheritance is suggested by the segregation in three generations of a moderate to severe mental retardation in seven males and by a milder intellectual impairment in two females, without any specific clinical, radiological, or biological feature. Two-point linkage analysis demonstrated significant linkage between the disorder and several markers in Xq28 (maximum LOD score [Zmax] = 2.71 at recombination fraction [theta] = 0); multipoint linkage analyses confirmed the significant linkage with a Zmax of 3.3 at theta = 0, at DXS1684. A recombination event observed with the flanking marker DXS8011 delineates a locus between this marker and the telomere. The approximate length of this locus is 8-9 cM, corresponding to 5.5-6 Mb. In an attempt to explain the variable intellectual impairment in females, we examined X-chromosome inactivation in all females of the family. Inactivation patterns in lymphocytes were random or moderately skewed, and no correlation between the phenotypic status and a specific inactivation pattern was observed. The interval of assignment noted in this family overlaps with five MRX loci previously reported in Xq28.

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008126 Lod Score The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for "logarithmic odds." Lod Scores,Score, Lod,Scores, Lod
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D011581 Psychological Tests Standardized tests designed to measure abilities (as in intelligence, aptitude, and achievement tests) or to evaluate personality traits. Parenting Stress Index,Trier Social Stress Test,Trier Stress Test,Psychologic Tests,Psychological Test,Test, Psychological,Tests, Psychological,Index, Parenting Stress,Psychologic Test,Stress Index, Parenting,Stress Test, Trier,Test, Psychologic,Test, Trier Stress,Trier Stress Tests
D011594 Psychometrics Assessment of psychological variables by the application of mathematical procedures. Psychometric
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D004303 Dosage Compensation, Genetic Genetic mechanisms that allow GENES to be expressed at a similar level irrespective of their GENE DOSAGE. This term is usually used in discussing genes that lie on the SEX CHROMOSOMES. Because the sex chromosomes are only partially homologous, there is a different copy number, i.e., dosage, of these genes in males vs. females. In DROSOPHILA, dosage compensation is accomplished by hypertranscription of genes located on the X CHROMOSOME. In mammals, dosage compensation of X chromosome genes is accomplished by random X CHROMOSOME INACTIVATION of one of the two X chromosomes in the female. Dosage Compensation (Genetics),Gene Dosage Compensation,Hypertranscription, X-Chromosome,X-Chromosome Hypertranscription,Compensation, Dosage (Genetics),Compensation, Gene Dosage,Compensation, Genetic Dosage,Dosage Compensation, Gene,Gene Dosage Compensations,Genetic Dosage Compensation,Genetic Dosage Compensations,Hypertranscription, X Chromosome,X Chromosome Hypertranscription
D005260 Female Females

Related Publications

V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
July 1996, American journal of medical genetics,
V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
November 1992, Human genetics,
V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
April 1993, American journal of medical genetics,
V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
January 1998, Annales de genetique,
V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
January 1982, Human genetics,
V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
May 2002, American journal of human genetics,
V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
January 2009, Medycyna wieku rozwojowego,
V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
January 1995, American journal of medical genetics,
V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
April 1999, American journal of medical genetics,
V des Portes, and P Billuart, and A Carrié, and L Bachner, and T Bienvenu, and M C Vinet, and C Beldjord, and G Ponsot, and A Kahn, and J Boué, and J Chelly
December 2008, American journal of medical genetics. Part A,
Copied contents to your clipboard!